CNHCNH Industrial
- Next report
- No date yet
- none in the next 8 weeks
- Last result
- $0.16Beat
- vs $0.10 expected on Nov 9
- Stock move on it
- +10.90%
- one session
- Price
- $12.19
- −2.44% today · $13.3B cap
Past and upcoming reports
1
| Nov 9, 2026 | Sep 30, 2026 | Before the market opens | $0.10 | Beat$0.16 | +10.90% |
After the report
Nov 9, 2026 report
CNH posted a 60% EPS beat, but weak revenue growth and leverage keep the recovery thesis mixed
CNH reported $0.16 EPS versus $0.10 estimated on November 9. Shares rose 1.92% to $12.495 on November 11, while no event-window reaction or post-earnings news was provided. The recovery case depends on full-year profit delivery despite -4.0% TTM revenue growth and 3.37 debt-to-equity.
Reported against expected
CNH reported $0.16 EPS for the quarter ended September 30, beating the $0.10 estimate by $0.06, or 60%.
Guidance
No quantified management guidance was provided. the identified forward catalyst was full-year profit delivery.
How the stock reacted
The stock rose $0.235, or 1.92%, to $12.495 on November 11. event-day, day-one, and day-two reaction data were unavailable.
What changed
Reported EPS was $0.16, 60% above the $0.10 consensus estimate.
What the price now assumes
A 1.92% rise to $12.495 suggests constructive reaction, tempered by 3.37 debt-to-equity leverage.
What it means for the business
Maintain a recovery bias. upgrade only if full-year profit delivery coincides with renewed revenue growth.
The next one to three months, as we saw it then
Better case35%
Profit recovery gains credibility if full-year delivery is followed by renewed revenue growth and the 42.91% next-year EPS growth forecast remains intact.
Base case40%
The EPS beat supports stabilization, but weak revenue and leverage keep CNH range-bound until operating growth improves.
Worse case25%
A demand slowdown could overwhelm the EPS beat if revenue remains contracting and high leverage increases earnings pressure.
If you hold it
Hold unless full-year profit delivery is missed or revenue remains contracting alongside leverage at or above 3.37.
If you are watching
Add only if revenue returns to growth and full-year profit delivery is confirmed. no trade if both remain unverified.
Scenario odds are a judgement, not measured.